Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
News
-
Collective efforts by civil society groups bar the way to Hepatitis C patents
Many hold the view that Gilead’s revolutionary treatment against hepatitis C (sofosbuvir) marked the beginning of a shift in position...
-
Truvada case shows civil society’s success with pre-grant opposition
The example of Gilead antiretroviral Truvada in Argentina and Brazil shows how civil society efforts to use patent opposition to...
-
Thailand: Evergreened patents cause unwarranted high drug prices
Transnational drug manufacturers’ tactics of obtaining unmerited patent applications have unnecessarily raised healthcare costs and impeded the growth of domestic...
-
Civil society key in TRIPS flexibility implementation
Civil society plays an instrumental role in actively defending access to affordable to medicines, making use of TRIPS flexibilities, and...
-
Launched: I-MAK’s Special Edition Roadmap on Tenofovir Alafenamide Fumarate (TAF)
A critical analysis of TAF, as part of a Roadmap series, aims to help the international community assess the best...
-
Gilead’s patent application on sofosbuvir rejected in Brazil
Rejected! That was the decision issued by Brazil’s National Institute of Industrial Property (INPI) over one of Gilead’s patent applications...
-
Ukraine eyes patent law reform after civil society push on medicines access
Ukrainian lawmakers are poised to approve sweeping patent reform legislation, driven in large part by a push by patients’ groups...
-
ADVOCATES PUBLISH COMMENTARY ON EXPANDING TREATMENT ACCESS FOR VIRAL HEPATITIS C
On 2 April 2018, an in-depth commentary on practical actions that can help increase access to HCV direct-action antivirals (DAAs)...
-
Botswana: Creating (radio) waves to show how intellectual property affects us all
BONELA is raising national awareness as to why intellectual property (IP) and access to medicines are relevant for everyone –...
-
8 videos that explain the tension between HIV activists and Big Pharma
From Hollywood blockbusters, to investigative documentaries, to our own short, satirical animation, here are eight videos that show how the...
-
Patent on Hep C drug rejected in Ukraine: Price of sofosbuvir will significantly reduce
The Ministry of Economic Development and Trade of Ukraine (MEDT) refused to grant the pharmaceutical company Gilead a patent for...
-
Patent law amendments approved by the Government of Ukraine
Stricter patent law amendments, proposed by our partner, the All-Ukrainian Network of People Living with HIV/AIDS (the Network), have been...